Login

Andreas Thorsheim, CEO of Otovo, discusses insights with analyst Roger Berntsen in this comprehensive video interview. 00:10:00

Share On Facebook Share On Twitter

Andreas Thorsheim is the Founder and CEO at Otovo 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
BigCommerce CEO Brent Bellm on the company's IPO | Brent Bellm, CEO, Bigcommerce Holdings Inc (NASDAQ: BIGC)
00:10:00
Gold and Copper Insights: Wayne Atwell on Current Market Trends
00:10:00
Cleary Gottlieb's Pro Bono Impact: Championing Justice and Social Change
00:10:00
no one could change the rules on you|Yoko Hongyu Li,Partner,Andreessen Horowitz
00:10:00
Blackstone Minerals Plans to Restart Tarkwa Nickel Sulfide Project in Vietnam for Lithium-Ion Battery Industry
00:10:00
Dispute Resolution Clauses in FIDIC Contracts | Tony Dymond - Partner of Debevoise & Plimpton LLP
00:10:00
China's Commodities Outlook: Managing Expectations Amidst Global Energy Transition
00:10:00
Bill Shaver Discusses Mining Safety and Leadership at Workplace Safety North
00:10:00
invests in and co-builds world-class startups|Mike Janke,Co-Founder & Investment Board Member,DataTribe
00:10:00
serve the worlds most extraordinary people who are building tomorrows companies today|Justin Overdorff,Partner,Lightspeed Venture Partners
00:10:00
Meet Ioannis, Senior Account Manager at NCAB Group, in this interview featuring PCB specialists from around the world.|Gene Sheridan, CEO of Navitas Semiconductor
00:10:00
Navigating Loss, Inheritance, and New Beginnings

© 2026 Nehu